Intracoronary enalaprilat to reduce microvascular damage during percutaneous coronary intervention (ProMicro) study

Journal of the American College of Cardiology

Volumn 61, Issue 6, 2013, Pages 615-621

  Mangiacapra, Fabio ^a   Peace, Aaron J ^a   Di Serafino, Luigi ^a   Pyxaras, Stylianos A ^a   Bartunek, Jozef ^a   Wyffels, Eric ^a   Heyndrickx, Guy R ^a   Wijns, William ^a   De Bruyne, Bernard ^a   Barbato, Emanuele ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

Author keywords

angiotensin converting enzyme inhibitors; coronary artery disease; coronary intervention; coronary microvascular function

Indexed keywords

ENALAPRILAT; PLACEBO; TROPONIN T;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY VASCULAR RESISTANCE; DOUBLE BLIND PROCEDURE; FEMALE; FRACTIONAL FLOW RESERVE; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; INTRACORONARY INFUSION; MALE; MICROVASCULATURE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 84873409851     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.025     Document Type: Article

References (33)

1. M.A. Pfeffer, E. Braunwald, L.A. Moye Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
2. S. Yusuf, J.B. Kostis, B. Pitt ACE inhibitors for myocardial infarction and unstable angina Lancet 341 1993 829
3. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
4. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
5. M.A. Leesar, H. Jneid, X.L. Tang, R. Bolli Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty J Am Coll Cardiol 49 2007 1607 1610
6. U. Schaefer, T. Kurz, H. Bonnemeier Intracoronary enalaprilat during angioplasty for acute myocardial infarction: alleviation of postischaemic neurohumoral and inflammatory stress? J Intern Med 261 2007 188 200
7. A. Prasad, S. Husain, A.A. Quyyumi Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin J Am Coll Cardiol 33 1999 796 804
8. L.A. Nikolaidis, A. Doverspike, R. Huerbin, T. Hentosz, R.P. Shannon Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism Circulation 105 2002 2785 2790
9. T. Kurz, U. Schafer, A. Dendorfer Effects of intracoronary low-dose enalaprilat as an adjunct to primary percutaneous transluminal coronary angiography in acute myocardial infarction Am J Cardiol 88 2001 1351 1357
10. N.H.J. Pijls, B. De Bruyne, L. Smith Coronary thermodilution to assess flow reserve Circulation 105 2002 2482 2486
11. E. Barbato, J. Bartunek, E. Wyffels, W. Wijns, G.R. Heyndrickx, B. De Bruyne Effects intravenous dobutamine on coronary vasomotion in humans J Am Coll Cardiol 42 2003 1596 1601
12. W.F. Fearon, L.B. Balsam, H.M. Farouque Novel index for invasively assessing the coronary microcirculation Circulation 107 2003 3129 3132
13. W. Aarnoudse, W.F. Fearon, G. Manoharan Epicardial stenosis severity does not affect minimal microcirculatory resistance Circulation 110 2004 2137 2142
14. M.K. Ng, A.C. Yeung, W.F. Fearon Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve Circulation 113 2006 2054 2061
15. M.J. Kern, H. Samady Current concepts of integrated coronary physiology in the catheterization laboratory J Am Coll Cardiol 55 2010 173 185
16. E. Barbato, W. Aarnoudse, W.R. Aengevaeren Validation of coronary flow reserve measurements by thermodilution in clinical practice Eur Heart J 25 2004 219 223
17. E. Barbato, F. Piscione, J. Bartunek Role of β2 adrenergic receptors in human atherosclerotic coronary arteries Circulation 111 2005 288 294
18. F. Mangiacapra, B. De Bruyne, A.J. Peace, N. Melikian, W. Wijns, E. Barbato High cholesterol levels are associated with coronary microvascular dysfunction J Cardiovasc Med 13 2012 439 442
19. K. Thygesen, J.S. Alpert, H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
20. A. Prasad, B.J. Gersh, M.E. Bertrand Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 477 486
21. T. Cuisset, M. Hamilos, N. Melikian Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation J Am Coll Cardiol 51 2008 1060 1065
22. E. Barbato, J. Marco, W. Wijns Direct stenting Eur Heart J 24 2003 394 403
23. V.J. Dzau Mechanism of protective effects of ACE inhibition on coronary artery disease Eur Heart J 19 Suppl J 1998 J2 J6
24. E.M. Lonn, S. Yusuf, P. Jha Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection Circulation 90 1994 2056 2069
25. Y. Shahin, J.A. Khan, N. Samuel, I. Chetter Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials Atherosclerosis 216 2011 7 16
26. G. Lembo, C. Morisco, F. Lanni Systemic hypertension and coronary artery disease: the link Am J Cardiol 82 3A 1998 2H 7H
27. C. Di Mario, J.W. Moses, T.J. Anderson Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler DESTINI Study Group (Doppler Endpoint STenting INternational Investigation) Circulation 102 2000 2938 2944
28. W. Wijns, P. Kolh, N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
29. E. Barbato, J. Bartunek, W. Aarnoudse Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses Eur Heart J 25 2004 2034 2039
30. W. Aarnoudse, M. Geven, E. Barbato, K.J. Botman, B. De Bruyne, N.H. Pijls Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease Am J Cardiol 96 2005 1627 1630
31. J. Herrmann, C. Von Birgelen, M. Haude Prognostic implication of cardiac troponin T increase following stent implantation Heart 87 2002 549 553
32. A. Prasad, M. Singh, A. Lerman, R.J. Lennon, D.R.J. Holmes, C.S. Rihal Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality J Am Coll Cardiol 48 2006 1765 1770
33. D.N. Feldman, L. Kim, A.G. Rene, R.M. Minutello, G. Bergman, S.C. Wong Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis Catheter Cardiovasc Interv 77 2011 1020 1030